Quanticate Blog Inside Project Optimus - FDA’s Initiative to Optimise Oncology Treatments

As oncology treatments advance, optimising dose selection has become a key focus for improving patient outcomes. The FDA’s Project Optimus aims to address this need by reshaping traditional dose-finding methods, prioritising both efficacy and long-term tolerability. In this article, we discuss the objectives and implications of Project Optimus, exploring its potential to transform oncology clinical trials and enhance cancer treatment strategies.